descript
studi
develop
southeast
brazil
set
biolog
sampl
obtain
twoyear
period
august
part
respiratori
viru
surveil
program
ministri
health
brazil
nasopharyng
aspir
npa
collect
patient
age
attend
either
emerg
room
primari
care
unit
patient
present
fever
temperatur
equal
greater
runni
nose
addit
one
follow
symptom
cough
myalgia
nasal
congest
headach
sore
throat
earach
within
five
day
symptom
onset
nasopharyng
aspir
procedur
part
routin
respiratori
viru
surveil
program
sampl
test
indirect
immunofluoresc
assay
iif
ftdrp
plu
multiplex
realtim
rtpcr
assay
seven
respiratori
virus
rsv
piv
inf
inf
b
hadv
screen
specimen
iif
use
respiratori
panel
viral
screen
identif
kittm
chemicon
intern
millipor
usa
accord
manufactur
instruct
twentythre
respiratori
pathogen
includ
human
respiratori
virus
five
bacteri
speci
test
use
multiplex
protocol
total
nucleic
acid
extract
use
magna
pure
lc
autom
extract
system
roch
switzerland
nucleic
acid
extract
npa
sampl
elut
final
volum
follow
magna
pure
lc
total
nucleic
acid
isol
roch
protocol
intern
rna
viru
control
brome
mosaic
viru
fasttrack
diagnost
luxembourg
introduc
lysi
buffer
specimen
monitor
sampl
extract
revers
transcript
multiplex
realtim
rtpcr
perform
use
ftdrp
plu
accord
manufactur
instruct
fasttrack
diagnost
reaction
volum
test
made
nucleic
acid
bufferenzym
mix
onestep
rtpcr
kit
ambion
life
technolog
usa
amplif
perform
abi
realtim
pcr
system
thermocycl
appli
biosystem
usa
follow
cycl
condit
use
min
min
cycl
fluoresc
read
taken
step
cycl
threshold
cycl
ct
valu
determin
manual
adjust
sampl
amplifi
six
parallel
reaction
contain
primer
probe
four
differ
target
detect
virus
pathogen
bacteria
addit
intern
control
reaction
posit
neg
viru
plasmid
control
provid
kit
includ
run
monitor
assay
perform
exploratori
analysi
data
perform
use
spss
softwar
packag
spss
inc
usa
ethic
research
ethic
committe
centr
health
scienc
feder
univers
santo
approv
studi
registr
present
result
patient
met
inclus
criteria
whose
sampl
analys
method
propos
studi
one
hundr
sixtytwo
outpati
male
femal
includ
studi
consist
adult
n
paediatr
n
individu
paediatr
age
group
consist
individu
year
age
includ
children
adolesc
accord
world
health
organ
criteria
median
age
entir
cohort
seven
year
rang
month
year
children
nine
year
age
account
sampl
analys
patient
recent
day
symptom
iif
detect
posit
specimen
influenza
viru
common
etiolog
agent
detect
inf
inf
b
correspond
sampl
respect
iif
techniqu
detect
singl
infect
eightyeight
specimen
posit
one
respiratori
virus
multiplex
realtim
rtpcr
tabl
influenza
viru
hrv
rsv
virus
frequent
detect
account
onethird
posit
sampl
regard
patient
age
group
influenza
virus
frequent
identifi
young
adult
year
age
virus
identifi
infant
year
old
except
piv
piv
ev
rsv
hrv
preval
sampl
posit
rsv
hrv
identifi
infant
viru
identifi
subject
year
old
figur
follow
bacteria
detect
streptococcu
pneumonia
n
staphylococcu
aureu
n
haemophilu
influenza
n
mycoplasma
pneumonia
chlamydophila
pneumonia
detect
tabl
six
specimen
posit
two
virus
codetect
occur
children
two
year
age
rsv
account
half
case
tabl
ii
codetect
involv
three
respiratori
virus
bacteri
pathogen
identifi
codetect
case
least
one
infecti
agent
viral
bacteri
pathogen
group
tabl
ii
laboratori
diagnosi
viral
respiratori
tract
infect
usual
accomplish
convent
techniqu
cultur
antigen
detect
test
limit
relat
delay
result
avail
monoclon
antibodi
newli
identifi
virus
mahoni
et
al
multiplex
pcr
assay
becom
import
tool
identif
etiolog
agent
ari
dabischruth
et
al
sanghavi
et
al
describ
recent
commerci
multiplex
ftdrp
realtim
rtpcr
assay
enhanc
diagnosi
ari
simultan
detect
respiratori
virus
sakthivel
et
al
new
version
ftdrp
assay
use
studi
expand
capac
detect
pathogen
viral
bacteri
speci
thu
increas
diagnost
potenti
test
half
studi
popul
children
nine
year
age
repres
occurr
ari
commun
paediatr
age
group
main
group
affect
ari
occur
threeeight
time
year
infant
young
children
incid
vari
invers
age
bryce
et
al
bezerra
et
al
viral
agent
frequent
identifi
influenza
virus
includ
inf
case
patient
uncompl
respiratori
infect
follow
hrv
rsv
sinc
april
inf
viru
spread
worldwid
given
countri
health
author
declar
sustain
transmiss
new
influenza
viru
brazil
ms
juli
assum
observ
low
frequenc
inf
relat
endpoint
present
studi
august
frequenc
influenza
viru
infect
observ
studi
consist
previous
publish
rate
vari
ari
case
studi
south
southeast
northeast
brazil
arruda
et
al
bellei
et
al
although
wide
interregion
variat
expect
larg
countri
differ
climat
variat
may
also
due
studi
design
differ
virus
screen
studi
frequent
identifi
children
except
influenza
virus
often
identifi
adult
paediatr
patient
document
recent
studi
pelat
et
al
second
preval
viral
agent
hrv
hrvposit
sampl
identifi
children
two
year
age
find
highlight
import
viru
infant
hrv
associ
recurr
respiratori
ill
wheez
age
group
jartti
et
al
picornavirus
may
etiolog
agent
ari
howev
hrv
main
viru
detect
case
common
cold
hayden
multicentr
studi
rhinovirus
often
associ
ari
even
peak
influenza
season
caruso
et
al
brazil
accord
arruda
et
al
hrv
frequent
viral
agent
detect
children
ari
frequenc
rsv
detect
similar
detect
raboni
et
al
report
rate
use
multiplex
rtpcr
respiratori
virus
eleven
rsv
case
studi
detect
children
two
year
age
rsv
antibodi
found
virtual
adult
children
older
three
year
age
one
year
age
children
antibodi
rsv
demonstr
high
frequenc
infect
young
age
domachowsk
rosenberg
keep
observ
frequenc
rsv
youngest
age
group
studi
highest
among
age
howev
studi
conduct
patient
wide
variabl
age
twothird
children
nine
studi
patient
children
two
year
age
henc
reason
consid
observ
rel
low
frequenc
rsv
could
attribut
least
part
underrepresent
patient
young
age
frequenc
hbov
case
occur
children
two
year
age
viru
frequent
identifi
age
group
although
pathogen
yet
well
defin
longtin
et
al
et
al
recent
higher
hbovposit
rate
document
inpati
compar
outpati
patient
attend
emerg
depart
suggest
signific
role
viru
pathogenesi
ari
xu
et
al
use
multiplex
realtim
rtpcr
increas
overal
viral
detect
rate
compar
iff
test
differ
like
due
high
sensit
viru
genom
detect
et
al
addit
sampl
posit
multiplex
realtim
rtpcr
correspond
respiratori
virus
test
use
iif
kit
hrv
hcov
hmpv
hbov
ev
find
confirm
import
use
panel
identifi
multipl
viral
agent
caus
ari
studi
six
case
viral
codetect
commonli
rsv
hrv
real
clinic
signific
infect
yet
fulli
elucid
recent
brazilian
studi
codetect
rsv
hrv
increas
length
hospitalis
time
supplement
oxygen
use
children
lower
respiratori
tract
infect
suggest
possibl
coinfect
among
virus
codetect
da
silva
et
al
case
codetect
observ
studi
occur
children
two
year
old
age
group
ari
case
frequent
quit
possibl
residu
nucleic
acid
sequenti
viral
infect
detect
simultan
multiplex
pcr
high
sensit
lesley
addit
lymphoid
tissu
may
serv
reservoir
respiratori
virus
asymptomat
individu
may
involv
transmiss
virus
commun
proencamodena
et
al
likelihood
pathogen
aetiolog
agent
given
infect
could
relat
ct
valu
realtim
pcr
reaction
lower
ct
valu
suggest
higher
load
pathogen
detect
may
turn
suggest
aetiolog
brittainlong
et
al
studi
ct
valu
well
cutoff
valu
posit
propos
manufactur
overal
bacteri
detect
rate
pneumonia
frequent
agent
identifi
despit
vaccin
program
pneumonia
one
main
caus
pneumonia
mortal
respons
least
sever
episod
death
worldwid
walker
et
al
bacteria
codetect
virus
specimen
potenti
pathogen
bacteria
detect
studi
could
reflect
transient
microbiota
nasopharyng
flora
may
associ
ari
howev
well
known
viral
infect
within
respiratori
tract
predispos
individu
bacteri
infect
notabl
disrupt
respiratori
mucos
epithelium
bakaletz
atyp
bacteria
pneumonia
c
pneumonia
detect
studi
popul
brazil
countri
respiratori
viru
surveil
program
use
convent
diagnost
techniqu
iif
larg
proport
biolog
sampl
remain
neg
even
clinic
evid
respiratori
infect
molecular
techniqu
realtim
pcr
import
tool
increas
detect
capac
larg
number
respiratori
pathogen
moreov
type
techniqu
contribut
correct
indic
antivir
medic
avoid
unnecessari
use
antibiot
promot
adopt
appropri
hospitalcontrol
measur
find
studi
show
applic
pcr
assay
realtim
multiplex
format
respiratori
pathogen
consider
increas
pathogen
detect
rate
compar
convent
method
highlight
role
influenza
viru
ari
case
patient
age
addit
report
circul
recent
describ
respiratori
virus
inf
hmpv
hbov
